Mariana Byndloss received her D.V.M. and a Ph.D. from Universidade Federal de Minas Gerais in Brazil. After completing her postdoctoral fellowship at the University of California, Davis, she started her lab in the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center in 2018.

Byndloss's research aims at understanding how inflammation-mediated changes in gut epithelial metabolism lead to gut dysbiosis and increased risk of infectious gastroenteritis by Salmonella typhimurium and noncommunicable diseases, namely obesity-associated cardiovascular disease and colon cancer. She has authored over 70 scientific publications, including some in high-impact journals such as Nature and Science, and she has been named a Clarivate Highly Cited Researcher in 2021 and 2022. She is a HHMI Freeman Hrabowski Scholar and has received multiple awards throughout her career, including the Science NOSTER Microbiome Prize (runner-up), a V Scholar Award (from V Foundation of Cancer Research), a Pew Biomedical Scholar Award (from the Pew Charitable Trusts) and a Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease Award. 

Lab website: https://www.vumc.org/byndloss-lab/byndloss-laboratory